Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POTASSIUM\RIBOFLAVIN 5^-PHOSPHATE: 12 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
12
Total FAERS Reports
5 (41.7%)
Deaths Reported
9
Hospitalizations
12
As Primary/Secondary Suspect
2
Life-Threatening
7
Disabilities

Active Ingredient: POTASSIUM CHLORIDE\RIBOFLAVIN 5^-PHOSPHATE SODIUM ·

First Report: 20200601 · Latest Report: 20210605

What Are the Most Common POTASSIUM\RIBOFLAVIN 5^-PHOSPHATE Side Effects?

#1 Most Reported
Nausea
10 reports (83.3%)
#2 Most Reported
Off label use
8 reports (66.7%)
#3 Most Reported
Hyponatraemia
8 reports (66.7%)

All POTASSIUM\RIBOFLAVIN 5^-PHOSPHATE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Nausea 10 83.3% 5 7
Constipation 8 66.7% 5 5
Hyponatraemia 8 66.7% 5 5
Off label use 8 66.7% 4 6
General physical health deterioration 7 58.3% 5 4
Abdominal distension 5 41.7% 5 2
Abdominal pain 5 41.7% 5 2
Abdominal pain upper 5 41.7% 0 5
Appendicitis 5 41.7% 5 2
Appendicolith 5 41.7% 5 2
Arthralgia 5 41.7% 0 5
Ascites 5 41.7% 5 2
Atrioventricular block first degree 5 41.7% 0 5
Blood cholesterol decreased 5 41.7% 0 5
Cardiogenic shock 5 41.7% 5 2
Depression 5 41.7% 0 5
Diabetes mellitus inadequate control 5 41.7% 0 5
Dizziness 5 41.7% 0 5
Drug dependence 5 41.7% 0 5
Drug interaction 5 41.7% 0 5

Who Reports POTASSIUM\RIBOFLAVIN 5^-PHOSPHATE Side Effects? Age & Gender Data

Gender: 61.5% female, 38.5% male. Average age: 79.6 years. Most reports from: PL. View detailed demographics →

Is POTASSIUM\RIBOFLAVIN 5^-PHOSPHATE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2020 1 1 1
2021 6 1 6

View full timeline →

What Is POTASSIUM\RIBOFLAVIN 5^-PHOSPHATE Used For?

IndicationReports
Product used for unknown indication 12

Official FDA Label for POTASSIUM\RIBOFLAVIN 5^-PHOSPHATE

Official prescribing information from the FDA-approved drug label.